EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities

Jixia Yang, Daowei Huang, Shouying Wang, Chen Wang, Yanbo Wang, Yi Zhou, Zhenhua Shang, Xiaolei Zhou

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Jixia Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China; Anhui Jing Ming Pharmaceutical Co., Ltd., Xuancheng 242600, Chi…. Hauptthemen laut MEDLINE: Antineoplastic Agents, c-Mer Tyrosine Kinase, Pyrimidines, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Department of Education of Hebei Province, Hebei University, Hebei University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The constitutive overexpression of Mer tyrosine kinase (MerTK), strongly associated with tumorigenesis and progression across multiple malignancies, establishes it as a promising therapeutic target for oncology discovery. In this study, we systematically designed and synthesized a series of 2-substituted aniline pyrimidine derivatives as potent MerTK inhibitors. The lead compound 15f demonstrated excellent inhibitory activity against Mer kinase with an IC50 value of 37.5 ± 2.7 nM, coupled with broad-spectrum antiproliferative activities against A2780, MDA-MB-231, and HCT116 cancer cell lines. Notably, 15f exhibited minimal hERG liability, addressing critical safety concerns. Mechanistic studies revealed dose-dependent inhibition of cancer cell migration and induction of apoptosis, while pharmacokinetic evaluation demonstrated favorable drug-like properties including high AUC, prolonged half-life, and good oral bioavailability (F: 32.4 %). The bioavailability of 15f was significantly higher than that of compound UNC2250 (F: 23 %). These integrated findings position 15f as a structurally novel and multi-faceted MerTK inhibitor for therapeutic application in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agentsc-Mer Tyrosine KinasePyrimidinesProtein Kinase InhibitorsDrug DesignAniline CompoundsHumansStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorMolecular StructureAdministration, OralDose-Response Relationship, DrugAnimalsApoptosisBiological AvailabilityCell Line, TumorRatsRats, Sprague-Dawley

Stichwörter der Autor:innen

2-substitutedaniline pyrimidineAntitumorInhibitorsMer kinase

Substanzen

Antineoplastic Agentsc-Mer Tyrosine KinasePyrimidinesProtein Kinase InhibitorsAniline CompoundsMERTK protein, humananiline

Autor:innen und Institutionen

  • School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China; Anhui Jing Ming Pharmaceutical Co., Ltd., Xuancheng 242600, China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China. Electronic address: huangdaowei321@163.com.
  • School of Food Science and Biology, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • Shijiazhuang Vortech Biotech Co., Ltd., Shijiazhuang 050051, China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China. Electronic address: zhenhuashang@126.com.

Förderung

  • Department of Education of Hebei Province
  • Hebei University
  • Hebei University of Chinese Medicine

Zitieren

APA

Yang, J., Huang, D., Wang, S., Wang, C., Wang, Y., Zhou, Y., Shang, Z., & Zhou, X. (2025). Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108591

Vancouver

Yang J, Huang D, Wang S, Wang C, Wang Y, Zhou Y, et al. Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108591

BibTeX
@article{Yang2025,
  author = {Yang, Jixia and Huang, Daowei and Wang, Shouying and Wang, Chen and Wang, Yanbo and Zhou, Yi and Shang, Zhenhua and Zhou, Xiaolei},
  title = {Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108591}
}
Kostenlos starten →